The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C

Tissue Antigens

Volumn 82, Issue 1, 2013, Pages 43-47

  Pollock, R A ^a   Chandran, V ^a   Pellett, F J ^a   Thavaneswaran, A ^a   Eder, L ^a   Barrett, J ^b   Rahman, P ^c   Farewell, V ^b   Gladman, D D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

HLA B; HLA C; Major histocompatibility complex class I chain related gene A; MICA 129; Psoriasis; Psoriatic arthritis

Indexed keywords

GENOMIC DNA; HLA B ANTIGEN; HLA C ANTIGEN; MICA;

ADULT; ALLELE; ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; JOINTS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; SKIN;

EID: 84879800651     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12126     Document Type: Article

References (23)

1. Ritchlin C. Psoriatic disease-from skin to bone. Nat Clin Pract Rheumatol 2007: 3: 698-706.
2. Gladman DD, Antoni C, Mease P, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005: 64 (Suppl II): ii14-7.
3. Nair RP, Stuart PE, Nistor I et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006: 78: 827-51.
4. Gudjónsson JE, Kárason A, Antonsdóttir AA et al. HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 2002: 118: 362-5.
5. Enerbäck C, Martinsson T, Inerot A et al. Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP). Acta Derm Venereol 1997: 77: 273-6.
6. Chandran V. The genetics of psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol 2013: 44: 149-56.
7. Eder L, Chandran V, Pellett F et al. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis 2012: 71: 50-5.
8. Winchester R, Mineyich G, Steshenko V et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 2012: 64: 1134-44.
9. González S, Martínez-Borra J, López-Vázquez A, García-Fernández S, Torre-Alonso JC, López-Larrea C. MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J Rheumatol 2002: 29: 973-8.
10. Grubić Z, Perić P, Eeèuk-Jelicić E et al. The MICA-A4 triplet repeats polymorphism in the transmembrane region confers additional risk for development of psoriatic arthritis in the Croatian population. Eur J Immunogenet 2004: 31: 93-8.
11. Gonzalez S, Martinez-Borra J, Torre-Alonso JC et al. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 1999: 42: 1010-6.
12. Pollock R, Chandran V, Barrett J et al. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens 2011: 77: 554-61.
13. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999: 285: 727-9.
14. Steinle A, Li P, Morris DL et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001: 53: 279-87.
15. López-Hernández R, Valdés M, Lucas D et al. Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Hum Immunol 2010: 71: 512-4.
16. Raache R, Belanteur K, Amroun H et al. Association of major histocompatibility complex class 1 chain-related gene a dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population. Clin Vaccine Immunol 2012: 19: 557-61.
17. Amroun H, Djoudi H, Busson M et al. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum Immunol 2005: 66: 1057-61.
18. Douik H, Ben Chaaben A, Attia Romdhane N et al. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. Hum Immunol 2009: 70: 45-8.
19. Boukouaci W, Busson M, Peffault de Latour R et al. MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease. Blood 2009: 114: 5216-24.
20. Taylor W, Gladman D, Helliwell P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006: 54: 2665-73.
21. Rahman P, Jones A, Curtis J et al. The Newfoundland population: a unique resource for genetic investigation of complex diseases. Hum Mol Genet 2003: 12 (Spec 2): R167-72.
22. Buhler S, Nunes JM, Nicoloso G, Tiercy JM, Sanches-Mazas A. The heterogeneous HLA genetic makeup of the Swiss population. PLoS One 2012: 7: e41400.
23. McGonagle D, Ash Z, Dickie L, McDermott M, Ausdin SZ. The early phase of psoriatic arthritis. Ann Rheum Dis 2011: 70 (Suppl 1): i71-6.